Litcius/Paper detail

Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis

Ilana Heckler, Iswariya Venkataraman

2022Journal of Neurophysiology31 citationsDOI

Abstract

Neuroaxonal damage is a feature of various neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). Phosphorylated neurofilament heavy chain (pNfH) is a cytoskeletal structural protein released as a result of axonal damage into the cerebrospinal fluid (CSF), and subsequently into the blood. Due to high specificity for neuronal cell damage, pNfH is advantageous over other biomarkers, for ALS disease identification. Here, we review the structure and function of neurofilaments and their role in detection of various neurodegenerative conditions. In addition, a retrospective meta-analysis was performed to depict the significance of pNfH as a valuable diagnostic and prognostic biomarker in ALS.

Topics & Concepts

Amyotrophic lateral sclerosisNeurofilamentBiomarkerCytoskeletonCerebrospinal fluidNeuroscienceMedicinePathologyChemistryDiseaseBiologyCellImmunohistochemistryBiochemistryAmyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchCancer-related gene regulation